Peripheral Arterial Disease Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Peripheral Arterial Disease Market is segmented By Treatment (Drug Therapy, Endovascular Therapy), By Disease (Peripheral Arterial Disease, Pulmonary Vascular Disease), By Patient (Adult, Elderly), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

Peripheral Arterial Disease Market is segmented By Treatment (Drug Therapy, Endovascular Therapy), By Disease (Peripheral Arterial Disease, Pulmonary ....

Peripheral Arterial Disease Market Size

Market Size in USD

CAGR6.8%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	6.8%
Market Concentration	High
Major Players	Novartis, Bayer, Pfizer, Amgen, Sanof

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Peripheral Arterial Disease Market Analysis

The peripheral arterial disease market is estimated to be valued at USD 4.8 Bn in 2024 and is expected to reach USD 7.61 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.8% from 2024 to 2031. The increasing prevalence of diabetes, obesity, and hypertension are major factors driving the growth of the peripheral arterial disease market.

Peripheral Arterial Disease Market Report Snapshots

Buy Now